Attorney Richard F. Malloy joined Wisner Baum in 2024, bringing nearly two decades of diverse legal experience to the firm. He focuses on complex litigation with an emphasis on plaintiff mass tort litigation. Currently, Richard is an integral member of the Zantac cancer litigation team, representing over 11,000 clients with claims pending in California and Delaware state courts.
Prior to joining Wisner Baum, Richard’s legal career spanned 18 years in compliance and civil litigation. His practice areas have included multi-district litigation, class-action securities fraud, pharmaceutical and medical device litigation, data privacy and security, internal risk and compliance investigations, and information governance. He also has 10 years of experience in regulatory and administrative roles, managing cross-disciplinary projects at prestigious institutions such as Harvard Medical School, Tufts University School of Medicine, and the Beth Israel Deaconess Medical Center in Boston.
A defining moment in Richard’s career was the Enron and WorldCom corporate fraud scandals of the early 2000s, which ignited his passion for holding corporate fraudsters accountable. He began his legal practice in Boston focusing on class-action securities fraud, in such matters as Carlson v. Xerox Corp. (against the company and its auditor KPMG) and In re Philip Services Corp. Securities Litigation (against the company, its auditor Deloitte, and certain underwriters). Richard also has significant experience in toxic tort litigation, including the Fresenius Granuflo/Naturalyte Dialysate multi-district litigation.
Beyond his legal work, Richard is committed to civic engagement. He actively promotes pedestrian safety and was involved in preserving San Francisco's Slow Streets Program into the post-COVID era. He is also an advocate for housing policy reform, frequently engaging with city supervisors and other local representatives to push for more expansive and sustainable policies to address the housing shortage and end the displacement of economically vulnerable communities.
